Impaired 24-h activity patterns are associated with an increased risk of Alzheimer’s disease, Parkinson’s disease, and cognitive decline

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
1 Online-Ressource.
Language
Englisch

Bibliographic citation
Impaired 24-h activity patterns are associated with an increased risk of Alzheimer’s disease, Parkinson’s disease, and cognitive decline ; volume:16 ; number:1 ; day:14 ; month:2 ; year:2024 ; pages:1-11 ; date:12.2024
Alzheimer's research & therapy ; 16, Heft 1 (14.2.2024), 1-11, 12.2024

Creator
Winer, Joseph R.
Lok, Renske
Weed, Lara
He, Zihuai
Poston, Kathleen L.
Mormino, Elizabeth C.
Zeitzer, Jamie M.
Contributor
SpringerLink (Online service)

DOI
10.1186/s13195-024-01411-0
URN
urn:nbn:de:101:1-2404221208333.199672407130
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 11:00 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Winer, Joseph R.
  • Lok, Renske
  • Weed, Lara
  • He, Zihuai
  • Poston, Kathleen L.
  • Mormino, Elizabeth C.
  • Zeitzer, Jamie M.
  • SpringerLink (Online service)

Other Objects (12)

Parkinson’s disease and Alzheimer’s disease: a Mendelian randomization study

Parkinson’s disease and Alzheimer’s disease: a Mendelian randomization study

Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease

Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease

Measuring compounds in exhaled air to detect Alzheimer´s disease and Parkinson´s disease

Measuring compounds in exhaled air to detect Alzheimer´s disease and Parkinson´s disease

SNAP25 is a potential target for early stage Alzheimer’s disease and Parkinson’s disease

SNAP25 is a potential target for early stage Alzheimer’s disease and Parkinson’s disease

Gene expression meta-analysis of Parkinson’s disease and its relationship with Alzheimer’s disease

Gene expression meta-analysis of Parkinson’s disease and its relationship with Alzheimer’s disease

Correction to: Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease

Correction to: Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease

Facial emotion expressivity in patients with Parkinson’s and Alzheimer’s disease

Facial emotion expressivity in patients with Parkinson’s and Alzheimer’s disease

Associations of Alzheimer's-related plasma biomarkers with cognitive decline in Parkinson's disease

Associations of Alzheimer's-related plasma biomarkers with cognitive decline in Parkinson's disease

Role of glucagon-like peptide-1 receptor agonists in Alzheimer’s disease and Parkinson’s disease

Role of glucagon-like peptide-1 receptor agonists in Alzheimer’s disease and Parkinson’s disease

Relevance of plasma biomarkers to pathologies in Alzheimer’s disease, Parkinson’s disease and frontotemporal dementia

Relevance of plasma biomarkers to pathologies in Alzheimer’s disease, Parkinson’s disease and frontotemporal dementia

Development of seed amplificafion assays as biomarkers for Alzheimer’s & Parkinson’s disease

Development of seed amplificafion assays as biomarkers for Alzheimer’s & Parkinson’s disease

Peripheral Leukocytosis Predicts Cognitive Decline but Not Behavioral Disturbances: A Nationwide Study of Alzheimer’s and Parkinson’s Disease Patients

Peripheral Leukocytosis Predicts Cognitive Decline but Not Behavioral Disturbances: A Nationwide Study of Alzheimer’s and Parkinson’s Disease Patients

Related objects